24 January 2022
Dear colleagues, if you are applying for financial support from the Agency for Health Research of the Czech Republic with a project of clinical trials of medicines this year, the national research infrastructure CZECRIN offers you its help. An integral part of the application for a grant from the Agency to support clinical trials of drugs is its positive assessment from the State Institute for Drug Control (SÚKL). We can offer you assistance not only in the preparation of documents and information necessary to obtain a statement from SÚKL, but also in submitting an application for the assessment of a clinical trial of drugs at SÚKL.
In case of your interest in CZECRIN cooperation, it is necessary to fill in the application for cooperation no later than 14 February 2022.
Working on the materials needed for SÚKL’s opinion on the clinical evaluation of drugs requires sufficient time, and therefore we cannot guarantee the timely preparation of the necessary documents in the event of later contact.